ERBB2 and non-small cell lung carcinoma: The chaperone HSP90α is important for the stability of and function of a wide range of oncoproteins, including BCR-ABL, ERBB2, EGFR, BRAF, and AKT, among others, and inhibitors of this protein are now in oncology clinical trials, including NSCLC [40].